Patents by Inventor Sangeeta GOSWAMI

Sangeeta GOSWAMI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING GLIOBLASTOMA
    Publication number: 20230255978
    Abstract: Aspects of the disclosure relate to a method of treating glioblastoma in a subject comprising administering to the subject a KDM6B inhibitor. In some aspects, the methods are performed in combination with an immunoterhapy. Further aspects relate to a composition comprising a KDM6B inhibitor and an immunotherapy.
    Type: Application
    Filed: May 11, 2021
    Publication date: August 17, 2023
    Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Sangeeta GOSWAMI, Padmanee SHARMA, James ALLISON
  • METHODS FOR TREATING BLADDER CANCER
    Publication number: 20230184771
    Abstract: The current disclosure provides for novel therapeutic methods by identifying cancer patient populations that may be treated effectively by immunotherapies. Accordingly, aspects of the disclosure relate to a method of treating cancer in a subject comprising administering to the subject immune checkpoint blockade (ICB) therapy after the subject has been determined to have increased expression of CXCL13 in a biological sample from the subject.
    Type: Application
    Filed: April 20, 2021
    Publication date: June 15, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: Padmanee Sharma, James Allison, Sangeeta Goswami, Hao Zhao
  • COMBINATION OF EZH2 INHIBITOR AND CHECKPOINT THERAPY FOR THE TREATMENT OF CANCER
    Publication number: 20210260051
    Abstract: Provided herein are methods of treating cancer comprising administering an EZH2 inhibitor which may be combined with an immune checkpoint inhibitor. Further provided herein are methods of depleting regulatory T cells (Tregs) in a subject comprising administering an EZH2 inhibitor to the subject. Also provided herein are pharmaceutical compositions comprising CPI-1205 and an immune checkpoint inhibitor.
    Type: Application
    Filed: June 14, 2019
    Publication date: August 26, 2021
    Applicant: Board of Regents, The University of Texas System
    Inventors: Padmanee SHARMA, James P. ALLISON, Sangeeta GOSWAMI